Intellectual Property, Pharmaceuticals and Public Health
Editor
- Kenneth C. Shadlen
- Samira Guennif
- Alenka Guzmán
- Narayanan Lalitha
Abstract
Individual chapters are listed in the "Chapters" tab
Suggested Citation
Download full text from publisher
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Samira Guennif, 2017. "Is Compulsory Licensing Bad for Public Health? Some Critical Comments on Drug Accessibility in Developing Countries," Applied Health Economics and Health Policy, Springer, vol. 15(5), pages 557-565, October.
- Guennif, Samira, 2015. "La licence obligatoire : outil emblématique de la protection de la santé publique au Sud," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, vol. 17.
- G. Alenka Guzmán Chávez. & Hortensia Gómez Víquez. & Francisco López Herrera., 2018. "Patentes y crecimiento económico, el caso de México durante el TLCAN," Economía: teoría y práctica, Universidad Autónoma Metropolitana, México, vol. 0(2), pages 177-204, Agosto.
- Olsen Tricia D. & Sinha Aseema, 2013. "Linkage politics and the persistence of national policy autonomy in emerging powers: patents, profits, and patients in the context of TRIPS compliance," Business and Politics, De Gruyter, vol. 15(3), pages 323-356, October.
Book Chapters
The following chapters of this book are listed in IDEAS- Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & N. Lalitha, 2011. "Globalization, Intellectual Property Rights, and Pharmaceuticals: Meeting the Challenges to Addressing Health Gaps in the New International Environment," Chapters, in: Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), Intellectual Property, Pharmaceuticals and Public Health, chapter 1, Edward Elgar Publishing.
- Heinz Klug, 2011. "Pharmaceutical Production and Access to Essential Medicines in South Africa," Chapters, in: Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), Intellectual Property, Pharmaceuticals and Public Health, chapter 2, Edward Elgar Publishing.
- Gaelle Krikorian, 2011. "Intellectual Property and Access to Medicines: Paradoxes in Moroccan Policy," Chapters, in: Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), Intellectual Property, Pharmaceuticals and Public Health, chapter 3, Edward Elgar Publishing.
- Tatiana Andia, 2011. "The Invisible Threat: Trade, Intellectual Property, and Pharmaceutical Regulations in Colombia," Chapters, in: Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), Intellectual Property, Pharmaceuticals and Public Health, chapter 4, Edward Elgar Publishing.
- Alenka Guzmán, 2011. "The Challenges of Constructing Pharmaceutical Capabilities and Promoting Access to Medicines in Mexico under TRIPS," Chapters, in: Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), Intellectual Property, Pharmaceuticals and Public Health, chapter 5, Edward Elgar Publishing.
- Matthew Flynn, 2011. "Corporate Power and State Resistance: Brazil’s Use of TRIPS Flexibilities for its National AIDS Program," Chapters, in: Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), Intellectual Property, Pharmaceuticals and Public Health, chapter 6, Edward Elgar Publishing.
- Kenneth C. Shadlen, 2011. "The Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health Policies," Chapters, in: Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), Intellectual Property, Pharmaceuticals and Public Health, chapter 7, Edward Elgar Publishing.
- Jean-Frédéric Morin & Mélanie Bourassa Forcier, 2011. "Pharmaceutical Patent Policy in Developing Countries: Learning from the Canadian Experience," Chapters, in: Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), Intellectual Property, Pharmaceuticals and Public Health, chapter 8, Edward Elgar Publishing.
- N. Lalitha, 2011. "Access to Indian Generic Drugs: Emerging Issues," Chapters, in: Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), Intellectual Property, Pharmaceuticals and Public Health, chapter 9, Edward Elgar Publishing.
- Mariko Watanabe & Luwen Shi, 2011. "Sufficient but Expensive Drugs: A Double-Track System that Facilitated Supply Capability in China," Chapters, in: Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), Intellectual Property, Pharmaceuticals and Public Health, chapter 10, Edward Elgar Publishing.
- Samira Guennif, 2011. "Access to Essential Drugs in Thailand: Intellectual Property Rights and Other Institutional Matters Affecting Public Health in a Developing Country," Chapters, in: Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), Intellectual Property, Pharmaceuticals and Public Health, chapter 11, Edward Elgar Publishing.
- Padmashree Gehl Sampath, 2011. "The TRIPS Agreement and Health Innovation in Bangladesh," Chapters, in: Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), Intellectual Property, Pharmaceuticals and Public Health, chapter 12, Edward Elgar Publishing.
More about this item
Keywords
Development Studies; Economics and Finance; Law - Academic; Politics and Public Policy Social Policy and Sociology;All these keywords.
JEL classification:
- B5 - Schools of Economic Thought and Methodology - - Current Heterodox Approaches
- E12 - Macroeconomics and Monetary Economics - - General Aggregative Models - - - Keynes; Keynesian; Post-Keynesian; Modern Monetary Theory
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:elg:eebook:13876. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Darrel McCalla (email available below). General contact details of provider: http://www.e-elgar.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.